Home Leadership Review Ceo Can Vijender Singh Transform A...
Ceo
CIO Bulletin,
20 July, 2026
Author:
Gayathri Sr
Seasoned healthcare leader steps in to drive next-level growth and innovation in India’s fast-evolving diagnostics sector.
In a significant leadership move that has caught the attention of the healthcare industry, Agilus Diagnostics has appointed Vijender Singh as its new Managing Director and CEO, effective July 20, 2026. The decision comes at a pivotal moment for the company, which continues to strengthen its position as one of India’s leading diagnostic service providers.
Vijender Singh succeeds Dr. Anand K, who served the organization for nearly six years.
Industry watchers are already asking: what changes will this experienced leader bring, and how quickly will they impact Agilus’ future?
Singh brings more than three decades of sharp leadership across diagnostics, healthcare, consumer health, and FMCG sectors. He previously served as Chairman and Managing Director of Diagnum Healthcare. Before that, he held the role of Group CEO at Metropolis Healthcare and CEO of Healthians. He also played a key role during Dr. Lal PathLabs’ successful IPO journey, helping build a strong retail-focused diagnostics model that many still admire today.
Dr. Ashutosh Raghuvanshi, Managing Director & CEO of Fortis Healthcare Limited and Chairman of Agilus Diagnostics, welcomed the appointment warmly.
“Singh’s deep expertise in business transformation and customer-centric growth will accelerate innovation and enhance the overall customer experience,” he noted.
Singh himself expressed strong enthusiasm. He is committed to expanding access to high-quality, reliable diagnostics across the country while creating lasting value for all stakeholders. His track record suggests he thrives on turning challenges into opportunities through smart operational improvements and people-focused strategies.
For Agilus Diagnostics, this appointment feels like a carefully timed strategic step. As competition intensifies in the diagnostics space, Singh’s experience in scaling businesses and putting customers first could prove decisive.
Readers and investors alike are curious: will this leadership change spark a new phase of rapid expansion and technological advancement?
The parent company, Fortis Healthcare Limited, announced the transition through an official press release, underlining the importance of continuity and fresh vision.
As reported by CIO Bulletin, this development highlights the growing emphasis on seasoned leadership in India’s healthcare sector, where operational excellence and innovation are becoming non-negotiable.
Everything you need to know about this news
The company selected Singh for his proven ability to drive business transformation, scale operations, and deliver customer-focused growth across multiple healthcare organisations.
With leadership stints at Metropolis Healthcare, Diagnum Healthcare, Healthians, and Dr. Lal PathLabs, including supporting a major IPO, Singh brings rare, hands-on expertise in both diagnostics and broader healthcare management
Singh has emphasised expanding access to high-quality diagnostics and improving customer experience, which could translate into faster, more reliable, and more accessible testing services.
The appointment became effective immediately on July 20, 2026.
Industry experts anticipate stronger operational excellence, innovation in service delivery, and strategic moves to strengthen the company’s market position across India.








Comments